LOC643037 Activators
LOC643037 utilize various mechanisms to enhance the protein's activity by modulating cellular cAMP levels and activating protein kinase A (PKA). Forskolin directly stimulates adenylyl cyclase, the enzyme responsible for converting ATP to cAMP, resulting in an immediate rise in cAMP levels within the cell. This increase in cAMP facilitates the activation of PKA, which then phosphorylates LOC643037, leading to its activation. Similarly, Isoproterenol, a beta-adrenergic agonist, activates adenylyl cyclase through beta-adrenergic receptor signaling. This receptor-mediated pathway also elevates cAMP levels and subsequently activates PKA, which is then able to phosphorylate and activate LOC643037. PGE2, another activator, exerts its effect through G-protein-coupled receptors, which again leads to the production of cAMP and the activation of PKA, resulting in the phosphorylation of LOC643037.
IBMX acts as a phosphodiesterase inhibitor, preventing the degradation of cAMP, thereby sustaining its cellular levels and facilitating continued PKA activity. Glucagon, through its receptor, also stimulates the production of cAMP, and thus, PKA activation and phosphorylation of LOC643037 follow. Epinephrine and Salbutamol, through their interaction with beta-adrenergic receptors, produce similar effects by increasing intracellular cAMP and activating PKA, which can phosphorylate LOC643037. L-858051, although less well-characterized, is known to activate adenylyl cyclase, suggesting a similar pathway leading to LOC643037 activation. Anagrelide and Rolipram, by inhibiting phosphodiesterases, increase cAMP levels, thereby allowing PKA to phosphorylate LOC643037. Lastly, Dopamine and Histamine, through their respective receptors, can stimulate adenylyl cyclase to enhance cAMP levels, subsequently activating PKA, which in turn activates LOC643037 through phosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, stimulates adenylyl cyclase via G-protein-coupled receptor signaling, which increases cAMP levels. The resultant PKA activation can phosphorylate and increase the activity of LOC643037. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein-coupled receptors, leading to cAMP production. The increase in cAMP activates PKA, which may phosphorylate and enhance the functional activity of LOC643037. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) inhibits phosphodiesterases, preventing the breakdown of cAMP. The sustained levels of cAMP can activate PKA, which in turn can phosphorylate LOC643037, resulting in its activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to beta-adrenergic receptors, stimulating adenylyl cyclase and increasing cAMP production. The cAMP-dependent pathway activates PKA, which then could phosphorylate and activate LOC643037. | ||||||
BAY 41-2272 | 256376-24-6 | sc-202491 sc-202491A | 5 mg 25 mg | $238.00 $728.00 | 4 | |
L-858051 is a potent adenylyl cyclase activator, which increases intracellular cAMP levels. This elevation in cAMP leads to the activation of PKA, which is known to phosphorylate specific target proteins, potentially including LOC643037. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide increases cAMP levels by inhibiting phosphodiesterases. The high levels of cAMP activate PKA, which can then phosphorylate and activate LOC643037. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 inhibitor, which results in increased cAMP levels in the cells. The subsequent activation of PKA may lead to the phosphorylation and activation of LOC643037. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol is a beta-2 adrenergic receptor agonist that induces adenylyl cyclase activity, increasing cAMP levels. This cascade activates PKA, which could then phosphorylate and activate LOC643037. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to its G-protein-coupled receptors, particularly dopamine D1-like receptors, leading to increased cAMP production. Elevated cAMP levels activate PKA, which may phosphorylate and activate LOC643037. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through its H2 receptor, can activate adenylyl cyclase, leading to increased cAMP levels. The rise in cAMP activates PKA, which may subsequently phosphorylate and activate LOC643037. | ||||||